FGFR1 and prostate cancer: A demonstration of GREM1-mediated activation of FGFR1 in vivo (independent from its inhibitory effect on BMP signaling) in prostate cancer would strengthen the argument that GREM1 promotes prostate cancer progression by activating FGFR1.